Molnupiravir Capsules 200mg(molaz 200 Mg)

200mg Tablet, Bottle

4.5 (154)

2,500

Molnupiravir Capsules 200mg Tablets is an oral antiviral medication used to treat mild to moderate COVID-19 in adults, particularly those at high risk of severe illness (such as due to obesity, older age, diabetes, or heart disease). It works by inhibiting the SARS-CoV-2 virus from replicating, reducing viral load and disease severity. It received emergency use approval from Indian, US, and UK regulatory authorities, and is not intended for patients requiring immediate hospitalization due to COVID-19.

Description

Introduction Of Molnupiravir Capsules 200mg:

Molnupiravir Capsules 200mg Tablet is the principal oral antiviral medicine that helps treat gentle to direct COVID-19 in grown-ups. It keeps the infection from duplicating, subsequently decreasing viral burden and sickness seriousness. The medication got crisis use endorsement from Indian medication administrative experts on December 28, 2021.

Molnupiravir 200mg Tablet is just shown in patients with gentle to direct COVID-19 side effects and who have a high gamble of creating extreme side effects. The gamble factors incorporate weight, more established age (>60 years), diabetes mellitus, and heart illnesses. Not showed in patients require quick hospitalization because of COVID-19. This medication has likewise been endorsed by the U.S. Food and Drug Administration (FDA) and the UK administrative organization for crisis use.

Uses Of Molnupiravir Capsules 200mg:

  • Treatment of Mild to direct Coronavirus sickness (COVID-19)

Mechanism Of Action Of Molnupiravir Capsules 200mg:

Molnupiravir 200mg Tablet is an antiviral medication. It works by restraining the SARS-CoV-2 infection from duplicating. This prevents the infection from delivering new duplicates and consequently diminishes the viral burden in the body.

Contact Us

Info Table
Brand Movfor
Packaging Size 40 CAPSULES IN ONE PACK
Manufacturer AZISTA
Strength 200mg
Composition MOLNUPIRAVIR 200MG
Form Capsules
Treatment COVID-19
Prescription/Non prescription Prescription
Vendor Info
Benefits
Reviews

Description

Introduction Of Molnupiravir Capsules 200mg:

Molnupiravir Capsules 200mg Tablet is the principal oral antiviral medicine that helps treat gentle to direct COVID-19 in grown-ups. It keeps the infection from duplicating, subsequently decreasing viral burden and sickness seriousness. The medication got crisis use endorsement from Indian medication administrative experts on December 28, 2021.

Molnupiravir 200mg Tablet is just shown in patients with gentle to direct COVID-19 side effects and who have a high gamble of creating extreme side effects. The gamble factors incorporate weight, more established age (>60 years), diabetes mellitus, and heart illnesses. Not showed in patients require quick hospitalization because of COVID-19. This medication has likewise been endorsed by the U.S. Food and Drug Administration (FDA) and the UK administrative organization for crisis use.

Uses Of Molnupiravir Capsules 200mg:

  • Treatment of Mild to direct Coronavirus sickness (COVID-19)

Mechanism Of Action Of Molnupiravir Capsules 200mg:

Molnupiravir 200mg Tablet is an antiviral medication. It works by restraining the SARS-CoV-2 infection from duplicating. This prevents the infection from delivering new duplicates and consequently diminishes the viral burden in the body.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Molnupiravir Capsules 200mg(molaz 200 Mg)”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Molnupiravir Capsules 200mg used for?
This Capsules 200mg (Molaz) is used to treat mild to moderate COVID-19 in adults at high risk of severe illness.
It is indicated for patients with risk factors such as obesity, age over 60, diabetes, or heart disease, and mild to moderate symptoms.
It works by inhibiting the SARS-CoV-2 virus from replicating, reducing viral load and disease severity. For more clinical details, see MedlinePlus Drug Information.
No, it is not indicated for patients who require immediate hospitalization due to COVID-19.
It has received emergency use approval from Indian, US (FDA), and UK regulatory authorities.
This Capsules 200mg (Molaz, brand Movfor) is manufactured by Azista, containing Molnupiravir 200mg, supplied as 40 capsules per pack.

Related products